Melatonin suppresses glioma metastasis under hypoxic conditions by inhibiting TGF-β/Smad-C-C motif chemokine ligand 20 (CCL20) activity and modulating EMT through the activation of Smad7.129. The gene discussed is TGFB1; the disease is central nervous system cancer.